Cargando…

Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease

Inflammation significantly impacts the progression of Huntington's disease (HD) and the mutant HTT protein determines a pro‐inflammatory activation of microglia. Mesenchymal stem/stromal cells (MSC) from the amniotic membrane (hAMSC), and their conditioned medium (CM‐hAMSC), have been shown to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giampà, Carmela, Alvino, Alessandra, Magatti, Marta, Silini, Antonietta R., Cardinale, Antonella, Paldino, Emanuela, Fusco, Francesca R., Parolini, Ornella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349233/ https://www.ncbi.nlm.nih.gov/pubmed/30585395 http://dx.doi.org/10.1111/jcmm.14113

Ejemplares similares

Selective Sparing of Striatal Interneurons after Poly (ADP-Ribose) Polymerase 1 Inhibition in the R6/2 Mouse Model of Huntington’s Disease
por: Paldino, Emanuela, et al.
Publicado: (2017)

The Immunomodulatory Properties of Amniotic Cells: The Two Sides of the Coin
por: Magatti, Marta, et al.
Publicado: (2018)

PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington’s Disease
por: Cardinale, Antonella, et al.
Publicado: (2015)

Modulation of Phospho-CREB by Systemically Administered Recombinant BDNF in the Hippocampus of the R6/2 Mouse Model of Huntington's Disease
por: Paldino, Emanuela, et al.
Publicado: (2019)

B Lymphocytes as Targets of the Immunomodulatory Properties of Human Amniotic Mesenchymal Stromal Cells
por: Magatti, Marta, et al.
Publicado: (2020)

Characterization of the Conditioned Medium from Amniotic Membrane Cells: Prostaglandins as Key Effectors of Its Immunomodulatory Activity
por: Rossi, Daniele, et al.
Publicado: (2012)

Priming with inflammatory cytokines is not a prerequisite to increase immune-suppressive effects and responsiveness of equine amniotic mesenchymal stromal cells
por: Lange-Consiglio, Anna, et al.
Publicado: (2020)

The Long Path of Human Placenta, and Its Derivatives, in Regenerative Medicine
por: Silini, Antonietta R., et al.
Publicado: (2015)

Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease
por: Giampà, Carmela, et al.
Publicado: (2010)

Amniotic MSCs reduce pulmonary fibrosis by hampering lung B‐cell recruitment, retention, and maturation
por: Cargnoni, Anna, et al.
Publicado: (2020)

Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington’s Disease
por: Paldino, Emanuela, et al.
Publicado: (2019)

Amniotic mesenchymal cells from pre‐eclamptic placentae maintain immunomodulatory features as healthy controls
por: Pianta, Stefano, et al.
Publicado: (2015)

Human amniotic mesenchymal stromal cells support the ex vivo expansion of cord blood hematopoietic stem cells
por: Orticelli, Valentina, et al.
Publicado: (2021)

The Cells and Extracellular Matrix of Human Amniotic Membrane Hinder the Growth and Invasive Potential of Bladder Urothelial Cancer Cells
por: Ramuta, Taja Železnik, et al.
Publicado: (2020)

Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest
por: Magatti, Marta, et al.
Publicado: (2012)

Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective
por: Papait, Andrea, et al.
Publicado: (2022)

Effect of human amniotic epithelial cells on pro‐fibrogenic resident hepatic cells in a rat model of liver fibrosis
por: Cargnoni, Anna, et al.
Publicado: (2017)

Mapping of the Human Amniotic Membrane: In Situ Detection of Microvesicles Secreted by Amniotic Epithelial Cells
por: Basile, Mariangela, et al.
Publicado: (2023)

The Multifaceted Roles of MSCs in the Tumor Microenvironment: Interactions With Immune Cells and Exploitation for Therapy
por: Papait, Andrea, et al.
Publicado: (2020)

Amniotic Membrane-Derived Stromal Cells Release Extracellular Vesicles That Favor Regeneration of Dystrophic Skeletal Muscles
por: Sandonà, Martina, et al.
Publicado: (2023)

Immunological and Differentiation Properties of Amniotic Cells Are Retained After Immobilization in Pectin Gel
por: Silini, Antonietta R., et al.
Publicado: (2018)

Placental Cells and Derivatives: Advancing Clinical Translation
por: Silini, Antonietta R., et al.
Publicado: (2018)

Mapping of the Human Placenta: Experimental Evidence of Amniotic Epithelial Cell Heterogeneity
por: Centurione, Lucia, et al.
Publicado: (2018)

Emerging Role of NLRP3 Inflammasome/Pyroptosis in Huntington’s Disease
por: Paldino, Emanuela, et al.
Publicado: (2022)

Perinatal Mesenchymal Stromal Cells and Their Possible Contribution to Fetal-Maternal Tolerance
por: Magatti, Marta, et al.
Publicado: (2019)

The Role of B Cells in PE Pathophysiology: A Potential Target for Perinatal Cell-Based Therapy?
por: Magatti, Marta, et al.
Publicado: (2021)

Human amnion favours tissue repair by inducing the M1‐to‐M2 switch and enhancing M2 macrophage features
por: Magatti, Marta, et al.
Publicado: (2016)

miRNA Reference Genes in Extracellular Vesicles Released from Amniotic Membrane-Derived Mesenchymal Stromal Cells
por: Ragni, Enrico, et al.
Publicado: (2020)

Editorial: Perinatal Derivatives and the Road to Clinical Translation, Volume I
por: Silini, Antonietta R., et al.
Publicado: (2021)

Editorial: Perinatal derivatives and the road to clinical translation, Volume II
por: Silini, Antonietta R., et al.
Publicado: (2022)

Amniotic Membrane Mesenchymal Cells-Derived Factors Skew T Cell Polarization Toward Treg and Downregulate Th1 and Th17 Cells Subsets
por: Pianta, Stefano, et al.
Publicado: (2014)

The mechanism of degeneration of striatal neuronal subtypes in Huntington disease
por: Rikani, Azadeh A., et al.
Publicado: (2014)

Functional connectivity modeling of consistent cortico-striatal degeneration in Huntington's disease
por: Dogan, Imis, et al.
Publicado: (2015)

Disclosing the molecular profile of the human amniotic mesenchymal stromal cell secretome by filter-aided sample preparation proteomic characterization
por: Muntiu, Alexandra, et al.
Publicado: (2023)

Mesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine
por: Papait, Andrea, et al.
Publicado: (2020)

Editorial: MSC-Derived Extracellular Vesicles and Secreted Factors as “Cell-Free” Therapeutic Alternatives in Regenerative Medicine
por: Ragni, Enrico, et al.
Publicado: (2022)

Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study
por: Bonomi, Arianna, et al.
Publicado: (2015)

Shaping the Future of Perinatal Cells: Lessons From the Past and Interpretations of the Present
por: Silini, Antonietta R., et al.
Publicado: (2019)

Pyroptotic cell death in the R6/2 mouse model of Huntington’s disease: new insight on the inflammasome
por: Paldino, Emanuela, et al.
Publicado: (2020)

Amniotic membrane‐mesenchymal stromal cells secreted factors and extracellular vesicle‐miRNAs: Anti‐inflammatory and regenerative features for musculoskeletal tissues
por: Ragni, Enrico, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5lqbkanmaqhbbb2p4flrfh63ef